Jennifer Maloney, n/a

Vice President
Regeneron Pharmaceuticals Inc.

Poster(s):

• (235) Dupilumab improves signs and symptoms of Chronic Spontaneous Urticaria regardless of baseline body mass index
  Wednesday, October 29, 2025